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Abstract Quality of life is an important patient-centered
outcome and predictor of mortality in heart failure, but
little is known about the role of personality as a determi-
nant of quality of life in this patient group. We examined
the inﬂuence of Type D personality (i.e., increased negative
emotions paired with emotional non-expression) on quality
of life in primary care heart failure patients, using a
prospective study design. Heart failure patients (n = 251)
recruited from 44 primary care practices in Germany
completed standardized questionnaires at baseline and
9 months. The prevalence of Type D was 31.9%. Type D
patients experienced poorer emotional (P\.001) and
physical quality of life (P = .01) at baseline and 9 months
compared to non-Type D patients. There was no signiﬁcant
change in emotional (P=.78) nor physical quality of life
(P = .74) over time; neither the interaction for time by
Type D for emotional (P=.31) nor physical quality of life
(P=.91) was signiﬁcant, indicating that Type D exerted a
stable effect on quality of life over time. Adjusting for
demographics, New York Heart Association functional
class, and depressive symptoms, Type D remained an
independent determinant of emotional (P = .03) but not
physical quality of life (P = .29). Primary care heart fail-
ure patients with a Type D personality experienced poorer
emotional but not physical quality of life compared to non-
Type D patients. Patients with this personality proﬁle
should be identiﬁed in primary care to see if their treatment
is optimal, as both Type D and poor quality of life have
been associated with increased morbidity and mortality.
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Introduction
Heart failure is a debilitating clinical syndrome with a poor
prognosis despite considerable improvements in treatment
options over the last decade (Hunt 2005). Dyspnoea,
oedema, ﬂuid retention, pulmonary congestion and fatigue
comprise common symptoms of heart failure, and although
not necessarily present at the same time within an indi-
vidual patient they all have a detrimental inﬂuence on
functional status and quality of life (Hunt 2005; Juenger
et al. 2002; Masoudi et al. 2004).
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DOI 10.1007/s10865-009-9236-1Quality of life has gained increased recognition as an
important patient-centered outcome (Krumholz et al. 2005)
and has been incorporated as a performance measure
for evaluating the quality of clinical care in the Improv-
ing Continuous Cardiac Care (IC3) registry (http://
www.improvingcardiaccare.org/Documents/IC3v1_Program
Summary.pdf),a recentinitiative bythe AmericanCollege of
Cardiology Foundation in the United States. Some studies
indicatethatheart failure patientsmay preferbetterqualityof
life over prolonged survival (Spertus 2008). Poor quality of
life, as assessed by patient self-report, has also beenshown to
predictprognosis,includingmortalityandrehospitalizationin
heart failure patients (Mommersteeg et al. 2009). Hence, for
themanagementofpatientsinclinicalpractice,knowledgeof
the patient’s quality of life and in particular the clinical and
psychological proﬁle of those patients who experience poor
quality of life is important for secondary prevention. Such
information may help identify patients who may need more
aggressive medical treatment or adjunctive psychological
intervention (Spertus 2008).
Previously, mood states, such as anxiety and depression,
have been identiﬁed as important determinants of quality of
life both in heart failure patients and in patients with cor-
onary artery disease (Pedersen et al. 2006; Rector et al.
1987; Schiffer et al. 2008a, b). However, little attention has
been paid to the role of personality factors in heart failure,
with only two studies focusing on the impact of the dis-
tressed (Type D) personality (i.e., increased tendency to
experience increased negative emotions paired with emo-
tional non-expression due to fear of rejection by others) on
quality of life in heart failure (Schiffer et al. 2008a, b,
2005). These studies were conducted in outpatients with
heart failure rather than primary care heart failure patients,
with one of the studies using a cross-sectional study design
(Schiffer et al. 2005). Both studies showed that Type D was
associated with poorer quality of life and health status,
adjusting for demographic and clinical characteristics,
including left ventricular dysfunction and New York Heart
Association (NYHA) functional class (Schiffer et al.
2008a, b, 2005). In heart failure, Type D has also been
related to increased levels of pro-inﬂammatory cytokines
(Denollet et al. 2009a, b), which are markers of poor
prognosis in heart failure (Dunlay et al. 2008), and with
late ([6 months) mortality (Schiffer et al. 2009). Given
that heart failure patients seen by their primary care phy-
sician may have a milder disease spectrum, it is important
to investigate whether ﬁndings from outpatients seen by
their cardiologist or heart failure nurse generalize to this
patient group. In the general cardiovascular literature, there
is accumulating evidence that Type D is a risk marker for
adverse health outcomes across different forms of cardio-
vascular disease (Pedersen and Denollet 2006). Type D
personality has also been shown to predict adverse health
outcomes in 482 older primary care patients above and
beyond personality traits encompassed in the Five Factor
Model of personality, indicating that Type D provides
unique risk that is not captured by standard personality
traits (Chapman et al. 2007).
In the current study, we examined (1) the inﬂuence of
Type D personality on quality of life at baseline and
9-month follow-up in primary care heart failure patients,
and (2) the extent to which the inﬂuence of personality on
quality of life is confounded by NYHA class and depres-
sive symptoms.
Methods
Patients and design
All 44 general practices within a radius of 30 km around
Go ¨ttingen, Germany, were selected for participation in this
study. In these practices, electronic patient data (date of
birth, sex, diagnosis) were exported via a deﬁned interface
and transferred to a database. This database was screened
for patients with the documented diagnosis of heart failure
using a speciﬁc search strategy based on structured stan-
dard query language. Subsequently, all general practitio-
ners received lists with patient identiﬁcation codes and
dates of birth for re-identiﬁcation of the patients in the
electronic practice information system. Based on a pre-
deﬁned algorithm, general practitioners were asked to
exclude patients from the lists if their diagnosis of heart
failure was not valid, if patients had a life-threatening ill-
ness, cancer, severe disability, were unable to communicate
(e.g., due to dementia), insufﬁciently proﬁcient in the
German language to complete questionnaires, had moved
to a region outside the study area, or were only seen by
locums (i.e., a temporary replacement physician).
Eligible patients were asked to complete a set of stan-
dardized and validated questionnaires at baseline and at
9 months, of whom 363 patients agreed. Information on
patient recruitment and baseline characteristics of the
sample have been published previously (Scherer et al.
2006). Of the 363 patients, 310 patients could be inter-
viewed at 9 months (Fig. 1). For the current study, analy-
ses were based on 251 patients, for whom it was possible to
calculate a scale score for the questionnaires under study.
Factors contributing to differences between patients in-
cluded in the analyses (n = 251) and excluded from
analyses (n = 59) were age and heart failure severity
according to NYHA classiﬁcation. Patients excluded from
analyses were more likely to be older (mean age 77.5) and
to have higher NYHA functional class at baseline (NYHA
II-IV 55.7%).
J Behav Med (2010) 33:72–80 73
123Thestudyprotocolwasapprovedbytheethics committee
of the University of Go ¨ttingen, Germany. All patients
providedwritteninformedconsent,andthestudywascarried
out in accordance with the Helsinki Declaration.
Materials
Demographic and clinical variables
Demographic variables included gender, age, marital sta-
tus, education, and employment status. Clinical variables
comprised NYHA class, as a measure of the patient’s
functional status. Except demographic variables and the
assessment of Type D personality and the depression
subscale of the Hospital Anxiety and Depression Scale, all
other assessments were performed at baseline as well as
9 months later.
Quality of life
Quality of life was assessed with the Minnesota Living
with Heart Failure Questionnaire, which is a 21-item dis-
ease-speciﬁc measure (Rector 2005; Rector et al. 1987).
Items are answered on a 6-point Likert scale from 0 (no) to
5 (very much). The total Minnesota Living with Heart
Failure Questionnaire score ranges from 0 to 105, with a
higher score indicating poorer quality of life. In addition to
a total score, it is possible to derive an emotional (5 items;
questions 17–21; score range 0–25) and physical dimension
(8 items; questions 2–7, 12–13; score range 0–40) of
quality of life (de Rivas et al. 2008; Rector 2005; Schiffer
et al. 2008a, b). A sample item of the emotional subscale is:
‘‘Making you feel you are a burden to your family or
friends’’. A sample item of the physical subscale is:
‘‘Making your walking about or climbing stairs difﬁcult’’.
For the purpose of the current study we used the emotional
and physical quality of life subscales rather than the total
score, as they represent two different facets of quality of
life, and it is possible that the predictors of poor emotional
versus physical quality of life may be different. The Min-
nesota Living with Heart Failure Questionnaire is a psy-
chometrically sound measure, with good internal
consistency as measured by Cronbach’s a = .91–.96 for
the total scale (Rector et al. 1987), and .94 and .88 for the
physical and emotional dimension, respectively (Rector
2005). In the current study, Cronbach’s a for the physical
dimension of the Minnesota Living with Heart Failure
Questionnaire was .91 and .82 for the emotional dimension.
Type D personality
The 14-item Type D Scale (DS14) was used to assess Type
D personality (Denollet 2005). The Type D Scale measures
two stable personality traits, that is negative affectivity
(7 items; e.g. ‘‘I often feel unhappy’’ and ‘‘I am often
irritated’’) and social inhibition (7 items; e.g. ‘ ‘ Ia ma
closed person’’ and ‘‘I ﬁnd it hard to start a conversation’’)
(Denollet 2005). All items are answered on a 5-point Likert
scale from 0 (false) to 4 (true). Patients are categorized as
Type D if they score C 10 on both subscales (Denollet
2005). Item-response theory has shown this cut-off to be
the most optimal (Emons et al. 2007). The Type D Scale
has good psychometric properties, with Cronbach’s
a = .88/.86 and 3-month test–retest reliability r = .72/.82
for the negative affectivity and social inhibition subscales,
respectively (Denollet 2005). The German version of the
Documented heart failure diagnosis
N=4120
Met exclusion criteria* (N=3027)
Invited to participate
N=1093
No consent or answer (N=671)
Informed consent
N=422
Post-hoc exclusion** (N=59)
Baseline questionnaire
N=363
Telephone interview after 9 month
N=310
Participation cancelled (N=25)
Severe disease (N=13)
Death (N=3)
Address unknown (N=12)
Fig. 1 Flow chart of study population. * No heart failure (n = 455);
terminal illness (n = 24); death (n = 639); patients seen by locums
(n = 469); other reasons (n = 1,440: export of electronic patient
record incorrect (486), dementia (377), severe psychiatric disease
(110)—the remaining patients (467) had either changed domicile or
general practitioner or had an urgent need of care, inability to
communicate or suffered from cancer). ** Consent to study
participation was withdrawn (21), questionnaire not ﬁlled in (34),
heart failure diagnosis not valid (2), communication problems (2)
74 J Behav Med (2010) 33:72–80
123Type D Scale has been validated in a sample of 2,421
participants, including cardiac and psychosomatic patients
and healthy factory workers, and found equivalent to the
Flemish original version (Grande et al. 2004). In the cur-
rent study, Crobach’s a for negative affectivity was .82 and
.83 for social inhibition. Type D is not confounded by
disease severity, as measured by left ventricular ejection
fraction (Martens et al. 2007) and NYHA class (Scherer
et al. 2006), indicating that patients with this personality
proﬁle do not have more severe heart disease than non-
Type D patients. Type D personality also distinguishes it-
self from depression, in that it is a chronic rather than an
episodic risk factor, and stipulates how patients deal with
their negative emotions, due to the inclusion of the social
inhibition component (Pedersen and Denollet 2006). The
Type D scale has been listed among the recommended
measures to use when screening for psychosocial risk
factors in clinical cardiology practice in order to identify
high-risk patients (Albus et al. 2004).
Depressive symptoms
The 7-item depression subscale of the Hospital Anxiety
and Depression Scale was used to assess symptoms of
depression (e.g. ‘‘I have lost interest in my appearance’’)
(Zigmond and Snaith 1983). All items are answered on a
4-point Likert scale from 0 to 3, with the score range being
0–21. The Hospital Anxiety and Depression Scale is a valid
and reliable instrument, as indicated in a recent review of
15 studies, with Cronbach’s a ranging from .67 to .90 for
the depression subscale (Bjelland et al. 2002). In the cur-
rent study, a Cronbach’s a of .84 was found. A cut-off C8
is used to indicate probable clinical levels of depression,
with sensitivity and speciﬁcity ranging between .70 and .90
for most reviewed studies (Bjelland et al. 2002). The
Hospital Anxiety and Depression Scale has also been
shown to predict mortality in patients referred for exercise
testing (Herrmann et al. 2000) and in heart failure patients
(Junger et al. 2005). Although the Hospital Anxiety and
Depression Scale is devoid of somatic symptoms and hence
would be expected to be unconfounded by symptoms of
somatic disease, we have previously shown that Hospital
Anxiety and Depression Scale scores increase with higher
NYHA class in heart failure patients (Scherer et al. 2006).
Statistical analyses
All data were analyzed using SPSS 17.0 for Windows
(SPSS Inc., Chicago, Illinois). Prior to statistical analyses,
we dichotomized NYHA class into NYHA I versus II-IV,
as only 26 patients were in class III and 4 patients in class
IV. For comparisons of Type D with non-Type D patients
on baseline characteristics, we used the Chi-square test
(Fisher’s exact text when appropriate) for nominal vari-
ables and Student’s t-test for continuous variables. The
Pearson correlation coefﬁcient was used to determine the
correlation between the Type D subcomponents negative
affectivity and social inhibition and quality of life at both
time points, whereas Spearman’s rho was used to evaluate
the correlation between Type D caseness and quality of
life. These relationships between the independent variable
(i.e., Type D) and the dependent variable (i.e., quality of
life) were investigated prior to further analyses, in order to
rule out that Type D would predict quality of life outcomes
solely due to there being too large an overlap between the
two constructs. Analysis of variance with repeated mea-
sures was used to examine changes in quality of life during
the 9-month follow-up period and the inﬂuence of Type D
personality on quality of life. Analysis of covariance was
used to adjust the inﬂuence of Type D on quality of life for
potential confounders; a priori based on the literature, we
had decided to include gender, age, marital status, educa-
tion, employment status, NYHA class, and depressive
symptoms as covariates in this analysis. All tests were two-
tailed, and a P-value \.05 was used to indicate statistical
signiﬁcance.
Results
Baseline characteristics of the sample
The prevalence of Type D personality was 31.9%. Baseline
characteristics for the total sample and stratiﬁed by Type D
personality are shown in Table 1. Heart failure patients
with a Type D personality disposition were slightly
younger and experienced more depressive symptoms
compared to non-Type D patients. No other statistically
signiﬁcant differences were found on baseline character-
istics between the two groups.
Extent of independence between the constructs Type D
personality and quality of life
In order to rule out that Type D would predict quality of
life outcomes solely due to there being too large an overlap
between the two constructs, we ﬁrst investigated the rela-
tionship between Type D and quality of life using corre-
lational analyses. Pearson’s correlations showed that the
Type D Scale negative affectivity component correlated
signiﬁcantly with emotional (r = .53; P\.001) and
physical quality of life (r = .40; P\.001) at baseline and
also with emotional (r = .50; P\.001) and physical
quality of life (r = .38; P\.001) at 9 months. Similarly,
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signiﬁcantly with emotional (r = .27; P\.001) and
physical quality of life (r = .18; P = .004) at baseline and
also with emotional (r = .27; P\.001) and physical
quality of life (r = .23; P\.001) at 9 months. Given that
a high score on the Minnesota Living with Heart Failure
Questionnaire reﬂects a poorer quality of life, higher scores
on the Type D Scale negative affectivity and social inhi-
bition components were associated with poorer emotional
and physical quality of life. Nevertheless, the shared vari-
ance between the subcomponents of the Type D Scale and
the quality of life scores ranged from only 3 to 28%, with
none of the correlations exceeding the cut-off[.85 (Munro
2001). This indicates that there is not a problem with
collinearity nor that there is a question of the argument
being circular if Type D is related to quality of life in
further analyses.
These results were conﬁrmed when relating Type D
caseness to quality of life scores, with the shared variance
between Type D personality and quality of life being lower
than when using continuous scores for the Type D sub-
components, although Type D was still signiﬁcantly cor-
related with baseline emotional (q = .28; P\.001) and
physical quality of life (q = .17; P = .009) and with
9-month emotional (q = .22; P\.001) and physical
quality of life (q = .15; P\.02).
The inﬂuence of Type D personality on quality of life
at baseline and 9 months (unadjusted)
Analysis of variance with repeated measures showed that
Type D patients experienced poorer emotional quality of
life both at baseline and 9 months compared to
non-Type D patients (F(1,249) = 24.784; P\.001; partial
eta-squared = .091) (Table 2). There was no signiﬁcant
change in emotional quality of life between baseline
and 9 months (F(1,249) = .076; P = .78; partial eta-
squared = .000), nor was there a differential change in
emotionalqualityoflifeovertimebetweenTypeDandnon-
Type D patients, as indicated by the non-signiﬁcant inter-
action effect for time by Type D (F(1,249) = 1.043;
P = .31; partial eta-squared = .004). Hence, Type D
exerted a stable effect on quality of life over time.
Similar results were found for the physical dimension of
quality of life, with Type D patients experiencing poorer
physical quality of life at both time points compared to non-
Type D patients (F(1,249) = 6.243; P = .01; partial eta-
squared = .024) (Table 2). There was also no change in
physical quality of life over time (F(1,249) = .115;
P = .74; partial eta-squared = .000), nor was the interac-
tion effect for time by Type D signiﬁcant (F(1,249) = .014;
P = .91;partialeta-squared = .000),indicatingthatTypeD
also exerted a stable effect on physical quality of life
over time.
The inﬂuence of Type D personality on quality of life
at baseline and 9 months (adjusted)
Type D was still a signiﬁcant independent determinant of
poor emotional quality of life (F(1,227) = 4.808; P = .03;
partial eta-squared = .021), adjusting for gender, age,
marital status, education, employment status, NYHA class,
Table 1 Baseline characteristics for the total sample and stratiﬁed by Type D personality
Total
(n = 251)
Type D
(n = 80)
Non-Type D
(n = 171)
P
Age, mean (SD) 71.9 (9.4) 70.0 (9.8) 72.8 (9.0) .03
Male gender 47.4% 48.8% 46.8% .88
Living with a partner 69.6% 65.0% 71.8% .35
Low education
a 73.6% 72.5% 74.1% .91
Employed 10.0% 11.8% 9.6% .77
NYHA class II–IV 42.6% 41.3% 43.3% .87
Depressive symptoms 21.5% 43.8% 11.1% \.001
a B9 years
Bold values are statistically signiﬁcant at the designed cut-off of P\.05
Table 2 Quality of life at baseline and 9 months, stratiﬁed by Type
D personality, presented as means (SDs)
Type D
(n = 80)
Non-Type D
(n = 171)
Emotional quality of life
Baseline 5.96 (5.92) 2.89 (3.75)
9 months 5.78 (5.72) 3.20 (3.92)
Physical quality of life
Baseline 16.33 (10.08) 12.99 (10.27)
9 months 16.44 (10.51) 13.22 (10.48)
Analysis of variance with repeated measures; a high score indicates
poor quality of life
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repeated measures. Younger age (F(1,227) = 4.947;
P = .03; partial eta-squared = .021), NYHA class II-IV
(F(1,227) = 27.550;P\.001;partialeta-squared = .108),
and depressive symptoms (F(1,227) = 56.181; P\.001;
partial eta-squared = .198) were also signiﬁcant determi-
nants of poor emotional quality of life. In adjusted analysis,
the within-subjects effect for time was still not signiﬁcant
(F(1,227) = .810; P = .37; partial eta-squared = .004),
indicating that there was no change in emotional quality of
life over time. None of the other interaction effects for time
bycovariatesweresigniﬁcant(P’s[.05),exceptforNYHA
class by time, with a plot of the estimated marginal means
indicating that patients in NYHA class II-IV experienced a
deterioration in emotional quality of life over time.
In adjusted analysis, Type D was no longer an indepen-
dent determinant of poor physical quality of life
(F(1,227) = 1.115; P = .29; partial eta-squared = .005).
The only covariates signiﬁcantly associated with poor
physical quality of life were female gender (F(1,227) =
6.560;P = .01;partialeta-squared = .028),NYHAclassII-
IV (F(1,227) = 149.759; P\.001; partial eta-squared =
.397), and depressive symptoms (F(1,227) = 25.085;
P\.001; partial eta-squared = .100). In adjusted analysis,
there was also nochange inphysical quality oflife over time
(F(1,227) = .005;P = .94;partialeta-squared = .000),nor
wereanyofthewithin-subjectseffectsfortimebycovariates
signiﬁcant (P’s[.05).
Discussion
In the current prospective study, primary care heart failure
patients with a Type D personality experienced poorer
emotional quality of life compared to non-Type D patients.
The inﬂuence of personality on emotional quality of life in
adjusted analysis could not be explained by demographic
characteristics, NYHA class, and depressive symptoms.
Although Type D personality was also associated with
worse physical quality of life in unadjusted analysis, this
relationship was no longer signiﬁcant when controlling for
demographic and clinical characteristics and depressive
symptoms. NYHA class and depressive symptoms were
also important, independent determinants of both poor
emotional and physical quality of life.
Previous studies have shown that mood states, such as
anxiety and depression, are important determinants of poor
quality of life in heart failure patients, but these studies
were either cross-sectional (Brenes 2007; Muller-Tasch
et al. 2007) or conducted in outpatients with heart failure
(Evangelista et al. 2008; Heo et al. 2008). The current
study extends those ﬁndings by showing that personality
factors add to the level of prediction of poor quality of life
above and beyond depressive symptoms. This ﬁnding is
consistent with a recent Dutch study of heart failure out-
patients, showing that Type D patients report poorer
emotional but not physical quality of life, as assessed by
means of both disease-speciﬁc and generic measures
(Schiffer et al. 2008a, b).
In the current study, we also found that higher NYHA
class was associated with poorer quality of life. In previous
studies, a worsening of functional status in heart failure
outpatients predicted a decline in quality of life (Masoudi
et al. 2004), and in a cross-sectional study of primary care
heart failure NYHA functional class was associated with
poor quality of life on several dimensions of the Short-
Form Health Survey (SF-36) (Khunti et al. 2007). NYHA
class III or IV has also been found to predict impairment in
quality of life after open heart surgery (Pelle et al. 2009)
and poor prognosis in heart failure (Andersson et al. 2008;
Muntwyler et al. 2002). Despite the predictive value of
NYHA class and its wide usage as a measure of functional
status in heart failure patients, its objectivity and repro-
ducibility are the subject of some debate (Raphael et al.
2007). There may also be some confounding between
NYHA class and speciﬁc psychological measures, as we
previously showed that Hospital Anxiety and Depression
Scale scores, but not Type D personality, increased with
higher NYHA class (Scherer et al. 2006).
The results of the current study have some implications
for research and clinical practice. First, our results
emphasize the importance of looking at the dimensions of
quality of life (i.e., emotional versus physical) separately,
as we only found a relationship between Type D person-
ality and emotional quality of life, but not physical quality
of life. This indicates that using a component or total score
of quality of life may mask differences between subgroups
on different aspects of quality of life. Second, previous
studies in outpatients with heart failure and coronary artery
disease have shown that Type D personality is associated
with adverse health outcomes, including mortality, mor-
bidity, and poor quality of life, independent of disease
severity (Schiffer et al. 2008a, b, 2005; Pedersen and
Denollet 2006; Denollet and Pedersen 2008). This was also
conﬁrmed in the current study, with patients with a Type D
personality experiencing poorer emotional quality of life.
To date, no randomized controlled trial targeting Type D
personality has been conducted, but preliminary evidence
suggests that these patients derive beneﬁts from cardiac
rehabilitation in terms of improved quality of life (Karlsson
et al. 2007; Pelle et al. 2008). Hence, identiﬁcation of this
high-risk subgroup of patients seems worthwhile from a
secondary prevention perspective, with respect to exam-
ining whether their heart failure is optimally managed or
whether other treatment initiatives should be implemented.
By analogy, we still do not know how to treat depression in
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leads to a concomitant improvement in survival (Berkman
et al. 2003). However, this does not mean that we should
not screen cardiac patients for depression nor that depres-
sion should be left untreated, as this would be unethical due
to the known inﬂuence of depression on compliance, life-
style modiﬁcations, participation in cardiac rehabilitation,
mortality, and morbidity (Whooley 2009). Third, there are
several advantages of using an instrument, such as the Type
D scale, to identify patients with a general vulnerability to
experience adverse health outcomes, over measures of
anxiety, depression, and quality of life. These include the
confounding of the latter measures with indices of somatic
disease, such as NYHA class and left ventricular dys-
function. In a previous study, using the same patient
sample as in the current study, we showed that a total score
on the Hospital Anxiety and Depression Scale was con-
founded by NYHA class, whereas this was not the case for
the Type D scale (Scherer et al. 2006). Similar confounding
of the Beck Depression inventory, but not the Type D
Scale, with indices of somatic disease has been found in
patients with coronary artery disease (Martens et al. 2007).
Moreover, evidence from patients with coronary artery
disease indicates that not all distressed patients can be
captured by standard measures of depression, and that de-
spite some overlap Type D provides unique information
above and beyond measures of depression. Of 1,205
myocardial infarction patients, 206 (17%) patients had a
clinical diagnosis of depression, 224 (19%) patients a Type
D personality, whereas only 90 (7%) had both forms of
distress (Denollet et al. 2009a, b). This may also be the
case for quality of life, when used as a screening instru-
ment rather than an outcome measure. Others have also
indicated that measures that are sensitive as outcome
measures may not necessarily be optimal screening
instruments (Hevey et al. 2004). Furthermore, a recent
study of patients with ischemic heart disease or heart
failure indicated that despite some overlap between the
Type D Scale and measures frequently used in cardiovas-
cular research, including the Hospital Anxiety and
Depression Scale, the Beck Depression Inventory, and the
State-Trait Anxiety Inventory, the Type D Scale was the
only examined measure that remained intact in its origi-
nally proposed form using factor analysis on item level and
second-order level (Pelle et al. 2009).
The results of the current study have some limitations.
First, given that the study was designed to examine pre-
dictors of patient-centered outcomes available in primary
care practices, we had little information on traditional risk
factors, such as co morbidity, hypercholesterolemia, left
ventricular dysfunction, etc. Although we cannot rule out
that left ventricular dysfunction may have confounded
the results, evidence for an impact of left ventricular
dysfunction on patient-centered outcomes, such as quality
of life, anxiety and depressive symptoms, is mixed, with
some (Bjelland et al. 2002; de Rivas et al. 2008) but not all
studies (Lewis et al. 2007; Schiffer et al. 2008a, b, 2005)
supporting such a relationship. Second, depressive symp-
toms were assessed by means of self-report rather than a
clinical diagnostic interview. However, the Hospital Anx-
iety and Depression Scale has good sensitivity and speci-
ﬁcity compared to the gold standard of a clinical diagnostic
interview (Bjelland et al. 2002), and has also been shown to
predict mortality in several cardiac patient groups (Herr-
mann et al. 2000; Junger et al. 2005). Third, patients ex-
cluded from analyses were more likely to be older and have
a higher NYHA class compared to patients included in
analyses, indicating that included patients had a less severe
spectrum of disease, which might have led to a bias.
Fourth, the results may primarily be generalizable to heart
failure patients in NYHA class I and II, given that patients
in NYHA class III and IV were under sampled. This
necessitated the somewhat arbitrary cut-off of NYHA class
I versus NYHA class II–IV for the statistical analyses.
Fifth, several measures are available with which to assess
quality of life of both a generic and disease-speciﬁc nature
and a narrow or broad focus in terms of the number of
domains of quality of life assessed. Although we chose to
use the Minnesota Living with Heart Failure Questionnaire,
which is a well accepted and frequently used disease-spe-
ciﬁc measure in heart failure, it only represents a limited
number of quality of life domains. Sixth, it could be argued
that the potential overlap between psychological factors
and between psychological factors and quality of life may
threaten the value of the results of the current study, as
Type D might solely predict quality of life outcomes due to
there being too large an overlap between the constructs.
However, the shared variance between the subcomponents
of the Type D Scale and the quality of life scores ranged
from only 3 to 28%, with none of the correlations
exceeding the cut-off[.85, indicating that there was not a
problem with collinearity (Munro 2001). Similarly, a re-
cent study of patients with ischemic heart disease or heart
failure examining the overlap between measures frequently
used in cardiovascular research, including the Type D
Scale and the Hospital Anxiety and Depression Scale,
showed that these measures are distinct despite some
overlap (Pelle et al. 2009). In the latter study, the Type D
Scale was the only of the examined measures for which the
original proposed structure remained intact using factor
analysis on item level and second-order level.
Despite these limitations this study also has several
strengths, including its prospective study design with the
assessment of quality of life at two time points, the use of
a disease-speciﬁc measure of quality of life, and the
inclusion of personality factors, which is a novel approach
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123in heart failure research. In addition, the study was con-
ducted in a relatively large group of patients selected
from the whole patient population of various practices by
means of a pre-deﬁned algorithm, and is therefore largely
representative of the elderly heart failure patient seen in
general practice. The relatively large number of exclu-
sions can be traced back to this algorithm, making it
unlikely that our sample was subject to an unintentional
selection bias.
Further research is warranted to examine the added
value of the Type D personality construct in primary care
heart failure patients, particularly with respect to whether
Type D affects mortality and rehospitalization in this
patient group. Such research should aim to include more
detailed information on the clinical characteristics of the
patients than was available in the current study, in order
to draw more ﬁrm conclusions. It would also be worth-
while to include other personality traits, such as com-
prised within the Five Factor Model of personality, to
establish that Type D has added value above and beyond
these traits as a predictor of health outcomes, as shown
in older primary care patients (Chapman et al. 2007).
Finally, further research on Type D should investigate
whether the construct can best be viewed as a taxonomy,
or whether patients in the grey zone around the cut-offs
for determining Type D personality are also at risk for
adverse health outcomes.
In conclusion, primary care heart failure patients with
a Type D personality experienced poorer emotional but
not physical quality of life compared to non-Type D
patients. The inﬂuence of Type D personality on emo-
tional quality of life could not be attributed to demo-
graphic characteristics, NYHA class, nor depressive
symptoms. Patients with this personality proﬁle should
be identiﬁed in primary care, as both Type D and poor
quality of life have been associated with mortality in this
patient group. This could be done with the brief, vali-
dated Type D Scale (DS14), which comprises little
burden to patients and to clinical practice. An interna-
tional committee providing recommendations for the
assessment of psychosocial risk factor in clinical cardi-
ology practice has also recommended the use of the
Type D Scale as one of the measures to identify high-
risk patients (Albus et al. 2004).
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